en

руководство

⌂ > руководство

[EN] FDA: Q1A(R2) Stability Testing of New Drug Substances and Products

This guidance is the second revision of Q1A Stability Testing of New Drug Substances and Products, which was first pu...

[EN] CPMP: Guideline on stability testing: stability testing of existing active substances and related finished products

The following guideline is an extension of the Note for Guidance on Stability testing of New Drug Substances and Prod...

[FDA] ANDAs: Stability Testing of Drug Substances and Products

This guidance recommends that abbreviated new drug applications (ANDAs) submitted under section 505(j) of the Federal...

National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 32 leading cancer centers dev...

Kidney Cancer: NCCN Guidelines for patients

Basic information on the cancer types, diagnostics, treatment, and list of terms.

Oral Cancers: NCCN Guidelines for patients

Basic information on the cancer types, diagnostics, treatment, and list of terms.

Acute Lymphoblastic Leukemia (adult): NCCN Guidelines for patients

Basic information on the cancer types, diagnostics, treatment, and list of terms.

Acute Lymphoblastic Leukemia (pediatric): NCCN Guidelines for patients

Basic information on the cancer types, diagnostics, treatment, and list of terms.

Acute Myeloid Leukemia: NCCN Guidelines for patients

Basic information on the cancer types, diagnostics, treatment, and list of terms.

Immunotherapy Side Effects: CAR T-Cell Therapy: NCCN Guideline for patients

Basic information on the cancer types, diagnostics, treatment, and list of terms.

Immunotherapy Side Effects: Immune Checkpoint Inhibitors.

NCCN Guideline for patients. Basic information on the cancer types, diagnostics, treatment, and list of terms.

Adolescent and Young Adult with Cancer: NCCN Guideline for patients

Basic information on the conditinos, diagnostics, treatment, and list of terms.

Еще результаты...

Title *

Choose resourses